RANJU JHA SINGH: Open Payments
NPI 1306559117 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$347 in 14 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $233 · 2025 $347
Food & beverage: $269Education: $78
| Company | Payments | Amount |
|---|---|---|
| SOBI, INC | 2 | $98 |
| Eisai Inc. | 2 | $39 |
| GENZYME CORPORATION | 1 | $35 |
| Janssen Biotech, Inc. | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $33 |
| PFIZER INC. | 1 | $27 |
| Gilead Sciences, Inc. | 1 | $19 |
| Merck Sharp & Dohme LLC | 1 | $17 |
| ARRAY BIOPHARMA INC | 1 | $16 |
| Genmab U.S., Inc. | 1 | $15 |
Products named: Lenvima, SARCLISA, ERLEADA, FRUZAQLA, XTANDI, Vonjo, Trodelvy, KEYTRUDA.
Industry payments across NC — which companies pay providers there.
